In blood-based PC diagnosis, CEA alone yields an average of 43% sensitivity and 82% specificity to distinguish PC from healthy controls [48], and has lower overall diagnostic accuracy than CA19-9 alone [49]. The gene discussed is CEACAM5; the disease is pachyonychia congenita.